Hydrocutan (Hydrocortisone)

Hydrocutan is applied topically to address a range of inflammatory skin disorders that cause redness, itching, scaling, and discomfort, providing localized relief without systemic exposure.

• Mild to moderate eczema (atopic dermatitis) where inflammation and itching are present.
• Contact dermatitis resulting from irritants or allergens.
• Plaque psoriasis with localized skin lesions.
• Generalized dermatitis of various etiologies.
• Allergic skin reactions such as hives or insect bites.
• Seborrheic dermatitis affecting scalp or facial areas.
• Pruritic skin conditions associated with minor burns or sun exposure.

• Hydrocortisone in Hydrocutan penetrates the stratum corneum and binds to intracellular glucocorticoid receptors. The receptor‑ligand complex translocates to the nucleus, where it interacts with glucocorticoid response elements, altering gene transcription. This results in decreased synthesis of pro‑inflammatory cytokines, prostaglandins, and leukotrienes, while up‑regulating anti‑inflammatory proteins such as annexin‑1. The net effect is reduced vascular permeability, edema, and immune cell activation at the site of application.

Topical hydrocortisone may cause local and, rarely, systemic adverse reactions. Reported effects are grouped by frequency.

Common

• Skin irritation, burning, or stinging at the application site.
• Dryness or peeling of the treated skin.
• Mild erythema or redness.
• Pruritus (itching) unrelated to the underlying condition.
• Folliculitis or acneiform eruptions.
• Transient swelling or edema at the site of application.

Serious

• Contact dermatitis or allergic reaction to the formulation.
• Skin atrophy, thinning, or striae with prolonged use.
• Telangiectasia (visible small blood vessels).
• Hypopigmentation or depigmentation of the skin.
• Systemic corticosteroid effects such as adrenal suppression (very rare).
• Delayed wound healing or increased susceptibility to infection.

When using Hydrocutan, certain precautions help minimize risks and ensure safe application.

• Avoid applying to broken, infected, or ulcerated skin unless directed by a healthcare professional.
• Do not use under occlusive dressings unless specifically advised, as this can increase absorption.
• Limit duration of continuous use; prolonged therapy may lead to skin thinning.
• Keep the product away from eyes, mucous membranes, and genital area unless indicated.
• Consult a physician before use in children, pregnant or breastfeeding individuals.
• Discontinue and seek medical advice if signs of allergic reaction develop.
• Store at room temperature, protected from moisture and direct sunlight.

Hydrocortisone can interact with other topical or systemic agents; awareness of potential interactions supports safe use.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area, which may increase systemic exposure.
• Application together with topical calcineurin inhibitors without medical supervision.
• Use with skin‑lightening agents that may exacerbate irritation.

Use with caution

• Combining with systemic corticosteroids; monitor for additive systemic effects.
• Use alongside antifungal or antibacterial creams if infection is present; assess for altered absorption.
• Applying over large body surface areas; consider reduced frequency to limit systemic absorption.